A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).

Monk BJ, Parkinson C, Lim MC, O'Malley DM, Oaknin A, Wilson MK, Coleman RL, Lorusso D, Bessette P, Ghamande S, Christopoulou A, Provencher D, Prendergast E, Demirkiran F, Mikheeva O, Yeku O, Chudecka-Glaz A, Schenker M, Littell RD, Safra T, Chou HH, Morgan MA, Drochýtek V, Barlin JN, Van Gorp T, Ueland F, Lindahl G, Anderson C, Collins DC, Moore K, Marme F, Westin SN, McNeish IA, Shih D, Lin KK, Goble S, Hume S, Fujiwara K, Kristeleit RS

Open source

DOI
10.1200/jco.22.01003
Published
2022 Dec 1
Container
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco.22.01003,
  title = {A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).},
  author = {Monk BJ and Parkinson C and Lim MC and O'Malley DM and Oaknin A and Wilson MK and Coleman RL and Lorusso D and Bessette P and Ghamande S and Christopoulou A and Provencher D and Prendergast E and Demirkiran F and Mikheeva O and Yeku O and Chudecka-Glaz A and Schenker M and Littell RD and Safra T and Chou HH and Morgan MA and Drochýtek V and Barlin JN and Van Gorp T and Ueland F and Lindahl G and Anderson C and Collins DC and Moore K and Marme F and Westin SN and McNeish IA and Shih D and Lin KK and Goble S and Hume S and Fujiwara K and Kristeleit RS},
  year = {2022},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.22.01003},
  url = {https://doi.org/10.1200/jco.22.01003}
}

RIS

TY  - JOUR
TI  - A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).
AU  - Monk BJ
AU  - Parkinson C
AU  - Lim MC
AU  - O'Malley DM
AU  - Oaknin A
AU  - Wilson MK
AU  - Coleman RL
AU  - Lorusso D
AU  - Bessette P
AU  - Ghamande S
AU  - Christopoulou A
AU  - Provencher D
AU  - Prendergast E
AU  - Demirkiran F
AU  - Mikheeva O
AU  - Yeku O
AU  - Chudecka-Glaz A
AU  - Schenker M
AU  - Littell RD
AU  - Safra T
AU  - Chou HH
AU  - Morgan MA
AU  - Drochýtek V
AU  - Barlin JN
AU  - Van Gorp T
AU  - Ueland F
AU  - Lindahl G
AU  - Anderson C
AU  - Collins DC
AU  - Moore K
AU  - Marme F
AU  - Westin SN
AU  - McNeish IA
AU  - Shih D
AU  - Lin KK
AU  - Goble S
AU  - Hume S
AU  - Fujiwara K
AU  - Kristeleit RS
PY  - 2022
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.22.01003
UR  - https://doi.org/10.1200/jco.22.01003
ER  - 

APA

BJ, M., C, P., MC, L., DM, O., A, O., MK, W., RL, C., D, L., P, B., S, G., A, C., D, P., E, P., F, D., O, M., O, Y., A, C., M, S., RD, L., T, S., HH, C., MA, M., V, D., JN, B., T, V. G., F, U., G, L., C, A., DC, C., K, M., F, M., SN, W., IA, M., D, S., KK, L., S, G., S, H., K, F., & RS, K. (2022). A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.22.01003

Source records